Sepsis Therapeutics Global Market Report 2025

Description

Sepsis therapeutics refer to the medical treatments and medications specifically aimed at managing sepsis, a life-threatening condition triggered by the body's extreme response to infection. The primary objective of these treatments is to control the infection, sustain vital functions, manage inflammation, and avert organ failure, thereby enhancing survival rates and aiding in patient recovery.

The key drug categories used in sepsis treatment include cephalosporins, aminoglycosides, glycopeptides, among others. Cephalosporins, a class of broad-spectrum antibiotics, are frequently prescribed for sepsis and other serious bacterial infections. These drugs can be administered through various methods, such as orally, via injection, or topically. They are distributed through different channels, including hospital pharmacies, retail pharmacies, and online platforms. These medications are primarily used in settings such as hospitals, clinics, and other healthcare environments.

The sepsis therapeutics market research report is one of a series of new reports from The Business Research Company that provides sepsis therapeutics market statistics, including the sepsis therapeutics industry global market size, regional shares, competitors with the sepsis therapeutics market share, detailed sepsis therapeutics market segments, market trends, and opportunities, and any further data you may need to thrive in the sepsis therapeutics industry. This sepsis therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sepsis therapeutics market size has grown rapidly in recent years. It will grow from $4.03 billion in 2024 to $4.43 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth observed in the historical period can be credited to factors such as the rising number of sepsis cases, heightened awareness surrounding early diagnosis and treatment, progress in antibiotic and antifungal therapies, increased healthcare spending, and regulatory backing for the advancement of sepsis treatments.

The sepsis therapeutics market size is expected to see strong growth in the next few years. It will grow to $6.41 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The projected growth in the forecast period is driven by factors such as the increasing prevalence of antimicrobial resistance, greater adoption of biomarker-based diagnostics, a growing emphasis on immunotherapy for sepsis treatment, expansion of hospital infrastructure in developing markets, and government efforts to enhance sepsis management. Key trends during this period include the development of precision medicine, integration of AI for early sepsis detection, a rise in combination therapies, an increase in clinical trials for new sepsis drugs, and an expanded use of rapid molecular diagnostics.

The growing prevalence of infectious diseases is expected to drive the sepsis therapeutics market forward. Infectious diseases, caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, are on the rise, primarily due to climate change. Changing temperatures and ecosystems are expanding the habitats of disease-carrying vectors such as mosquitoes, leading to the spread of illnesses such as malaria and dengue fever. Sepsis therapeutics address these infectious diseases by targeting the infection itself, reducing inflammation, and supporting organ function to prevent life-threatening complications. According to the National Library of Medicine, in January 2023, infectious diseases are responsible for over 52 million deaths annually, with nearly half of the global population at risk. Each year, approximately 14 million children under five die, and 70% of these deaths are linked to preventable diseases that could be avoided through vaccination. Thus, the increasing prevalence of infectious diseases is a key factor driving the growth of the sepsis therapeutics market.

Companies in the sepsis diagnostics market are focused on developing innovative diagnostic technologies to improve sepsis detection and management. Advances in rapid molecular tests, which can detect pathogens quickly and accurately, are crucial for early diagnosis, better patient outcomes, and reduced mortality rates caused by delayed detection. These rapid molecular tests use advanced techniques such as PCR or isothermal amplification to identify pathogens by detecting their genetic material. For example, in November 2023, Inflammatix Inc., a US-based biotechnology company, announced the completion of its TriVerity Acute Infection and Sepsis Test System. This system includes the Myrna Instrument and the TriVerity Cartridge, designed for emergency department use to assess the likelihood of bacterial or viral infections and the risk of acute decompensation in patients with suspected infections and sepsis.

In January 2025, Partner Therapeutics, Inc. (PTx), a US-based biotechnology company specializing in sepsis therapeutics, partnered with the Biomedical Advanced Research and Development Authority (BARDA) to fund a Phase 2 study on the safety and optimal dosing of LEUKINE (sargramostim, rhu GM-CSF) in sepsis patients. This collaboration aims to enhance sepsis treatment by developing tools to measure immune status, enabling more targeted immunomodulatory therapies. BARDA, a US government department dedicated to biomedical advanced research, is supporting this initiative.

Major players in the sepsis therapeutics market are Pfizer Inc., AstraZeneca plc, GSK plc, Eli Lilly and Company, Viatris Inc., Astellas Pharma Inc., inthelia, La Jolla Pharmaceutical Co., Cytovale Inc., Aridis Pharmaceuticals Inc., Partner Therapeutics Inc., T2 Biosystems Inc., Modus Therapeutics, InflaRx GmbH, Adrenomed AG, Sepsia Therapeutics, Endpoint Health, Prenosis Inc., Spectral Medical Inc, Matisse Pharmaceuticals B.V.

North America was the largest region in the sepsis therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sepsis therapeutics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sepsis therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sepsis therapeutics market consists of revenues earned by entities providing services such as pharmaceutical interventions, supportive therapies, and diagnostic solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The sepsis therapeutics market also includes sales of antibiotics, intravenous fluids, vasopressors, and advanced therapies aimed at controlling infection, stabilizing patients, and preventing organ failure. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sepsis Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sepsis therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sepsis therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sepsis therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Class: Cephalosporin; Aminoglycosides; Glycopeptide; Other Drug Classes
2) By Route Of Administration: Oral; Injectable; Topical
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
4) By Application: Hospitals; Clinics; Other Applications
Subsegments:
1) By Cephalosporin: First-Generation Cephalosporins; Second-Generation Cephalosporins; Third-Generation Cephalosporins; Fourth-Generation Cephalosporins; Fifth-Generation Cephalosporins
2) By Aminoglycosides: Gentamicin; Amikacin; Tobramycin; Streptomycin; Other Aminoglycosides
3) By Glycopeptide: Vancomycin; Teicoplanin; Dalbavancin; Oritavancin; Other Glycopeptides
4) By Other Drug Classes: Carbapenems; Beta-Lactamase Inhibitors; Fluoroquinolones; Macrolides; Polymyxins
Companies Mentioned: Pfizer Inc.; AstraZeneca plc; GSK plc; Eli Lilly and Company; Viatris Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r35586

1. Executive Summary

2. Sepsis Therapeutics Market Characteristics

3. Sepsis Therapeutics Market Trends And Strategies

4. Sepsis Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Sepsis Therapeutics Growth Analysis And Strategic Analysis Framework

5.1. Global Sepsis Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Sepsis Therapeutics Market Growth Rate Analysis
5.4. Global Sepsis Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Sepsis Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Sepsis Therapeutics Total Addressable Market (TAM)

6. Sepsis Therapeutics Market Segmentation

6.1. Global Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cephalosporin
Aminoglycosides
Glycopeptide
Other Drug Classes
6.2. Global Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Injectable
Topical
6.3. Global Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.4. Global Sepsis Therapeutics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Other Applications
6.5. Global Sepsis Therapeutics Market, Sub-Segmentation Of Cephalosporin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
First-Generation Cephalosporins
Second-Generation Cephalosporins
Third-Generation Cephalosporins
Fourth-Generation Cephalosporins
Fifth-Generation Cephalosporins
6.6. Global Sepsis Therapeutics Market, Sub-Segmentation Of Aminoglycosides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gentamicin
Amikacin
Tobramycin
Streptomycin
Other Aminoglycosides
6.7. Global Sepsis Therapeutics Market, Sub-Segmentation Of Glycopeptide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Vancomycin
Teicoplanin
Dalbavancin
Oritavancin
Other Glycopeptides
6.8. Global Sepsis Therapeutics Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Carbapenems
Beta-Lactamase Inhibitors
Fluoroquinolones
Macrolides
Polymyxins

7. Sepsis Therapeutics Market Regional And Country Analysis

7.1. Global Sepsis Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Sepsis Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sepsis Therapeutics Market

8.1. Asia-Pacific Sepsis Therapeutics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sepsis Therapeutics Market

9.1. China Sepsis Therapeutics Market Overview
9.2. China Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sepsis Therapeutics Market

10.1. India Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sepsis Therapeutics Market

11.1. Japan Sepsis Therapeutics Market Overview
11.2. Japan Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sepsis Therapeutics Market

12.1. Australia Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sepsis Therapeutics Market

13.1. Indonesia Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sepsis Therapeutics Market

14.1. South Korea Sepsis Therapeutics Market Overview
14.2. South Korea Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sepsis Therapeutics Market

15.1. Western Europe Sepsis Therapeutics Market Overview
15.2. Western Europe Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sepsis Therapeutics Market

16.1. UK Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sepsis Therapeutics Market

17.1. Germany Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sepsis Therapeutics Market

18.1. France Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sepsis Therapeutics Market

19.1. Italy Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sepsis Therapeutics Market

20.1. Spain Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sepsis Therapeutics Market

21.1. Eastern Europe Sepsis Therapeutics Market Overview
21.2. Eastern Europe Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sepsis Therapeutics Market

22.1. Russia Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sepsis Therapeutics Market

23.1. North America Sepsis Therapeutics Market Overview
23.2. North America Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sepsis Therapeutics Market

24.1. USA Sepsis Therapeutics Market Overview
24.2. USA Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sepsis Therapeutics Market

25.1. Canada Sepsis Therapeutics Market Overview
25.2. Canada Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sepsis Therapeutics Market

26.1. South America Sepsis Therapeutics Market Overview
26.2. South America Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sepsis Therapeutics Market

27.1. Brazil Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sepsis Therapeutics Market

28.1. Middle East Sepsis Therapeutics Market Overview
28.2. Middle East Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sepsis Therapeutics Market

29.1. Africa Sepsis Therapeutics Market Overview
29.2. Africa Sepsis Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Sepsis Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Sepsis Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sepsis Therapeutics Market Competitive Landscape And Company Profiles

30.1. Sepsis Therapeutics Market Competitive Landscape
30.2. Sepsis Therapeutics Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. GSK plc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Sepsis Therapeutics Market Other Major And Innovative Companies

31.1. Astellas Pharma Inc.
31.2. inthelia
31.3. La Jolla Pharmaceutical Co.
31.4. Cytovale Inc.
31.5. Aridis Pharmaceuticals Inc.
31.6. Partner Therapeutics Inc.
31.7. T2 Biosystems Inc.
31.8. Modus Therapeutics
31.9. InflaRx GmbH
31.10. Adrenomed AG
31.11. Sepsia Therapeutics
31.12. Endpoint Health
31.13. Prenosis Inc.
31.14. Spectral Medical Inc
31.15. Matisse Pharmaceuticals B.V.

32. Global Sepsis Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sepsis Therapeutics Market

34. Recent Developments In The Sepsis Therapeutics Market

35. Sepsis Therapeutics Market High Potential Countries, Segments and Strategies

35.1 Sepsis Therapeutics Market In 2029 - Countries Offering Most New Opportunities
35.2 Sepsis Therapeutics Market In 2029 - Segments Offering Most New Opportunities
35.3 Sepsis Therapeutics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer